CytoDyn
1111 Main Street
Suite 660
Vancouver
Washington
98660
United States
Website: http://www.cytodyn.com/
308 articles about CytoDyn
-
CytoDyn Announces Plans to Move Forward With Next Stage of Research of CytoFelineâ„¢
5/17/2012
-
CytoDyn Engages the Trout Group for Investor Relations Services
4/16/2012
-
CytoDyn Presenting at The Wall Street Forum's 23rd Annual Analyst Conference in New York, New York
4/4/2012
-
Ismail Abdul Fattah Agrees to Become CytoDyn's Senior Advisor of Business Development for the Middle East
1/19/2012
-
CytoDyn Presenting Update on its Therapeutic Antibody Programs at the Therapeutic Potential of Antibodies for HIV Meeting in Boston, MA
1/17/2012
-
CytoDyn Appoints Anthony D. Caracciolo to Serve as a Member of the Board of Directors
12/21/2011
-
CytoDyn Enters into Research Funding and Option Agreement With The Scripps Research Institute
11/17/2011
-
CytoDyn Announces Humanized Cytolin(R) Provisional Patent Application Filed for the Treatment of HIV/AIDS
9/26/2011
-
CytoDyn Announces Consulting Arrangement with SDG, LLC
9/9/2011
-
CytoDyn Announces Provisional FIV Patent Filing
8/8/2011
-
CytoDyn Announces New Role for Nader Pourhassan
7/6/2011
-
CytoDyn Elects New President and CEO
12/9/2010
-
CytoDyn Welcomes Banker Kenneth J. Van Ness to Its Board of Directors
6/17/2010
-
CytoDyn Raises Three Million Dollars in Private Placements
3/31/2010
-
CytoDyn Increases Study Budget to Accelerate Clinical Trial
3/22/2010
-
CytoDyn Begins Full Humanization of Cytolin(R)
3/17/2010
-
Enrollment Open for Clinical Trial of Cytolin(R), a Novel Immune Therapy from CytoDyn for Treating Early HIV Infection
1/19/2010
-
CytoDyn's New Approach to Drug Development: Why We Think It's Better
1/6/2010
-
CytoDyn Engages Litchfield Enterprises for Investor Relations
11/18/2009
-
CytoDyn Transfers Research on Novel AIDS Drug to Massachusetts General Hospital
10/8/2009